MENU
+Compare
NVS
Stock ticker: NYSE
AS OF
Nov 13, 04:59 PM (EDT)
Price
$131.91
Change
-$0.38 (-0.29%)
Capitalization
250.98B

NVS Novartis AG Forecast, Technical & Fundamental Analysis

Novartis develops and manufactures innovative drugs... Show more

NVS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for NVS with price predictions
Nov 12, 2025

NVS's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for NVS turned positive on November 11, 2025. Looking at past instances where NVS's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 11, 2025. You may want to consider a long position or call options on NVS as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

NVS moved above its 50-day moving average on November 11, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NVS advanced for three days, in of 343 cases, the price rose further within the following month. The odds of a continued upward trend are .

NVS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The 10-day moving average for NVS crossed bearishly below the 50-day moving average on November 03, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NVS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for NVS entered a downward trend on November 07, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.727) is normal, around the industry mean (9.612). P/E Ratio (18.097) is within average values for comparable stocks, (23.835). Projected Growth (PEG Ratio) (1.078) is also within normal values, averaging (2.037). Dividend Yield (0.030) settles around the average of (0.028) among similar stocks. P/S Ratio (4.630) is also within normal values, averaging (3.560).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NVS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

View a ticker or compare two or three
NVS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

NVS is expected to report earnings to fall 12.44% to $1.97 per share on February 04

Novartis AG NVS Stock Earnings Reports
Q4'25
Est.
$1.97
Q3'25
Missed
by $0.02
Q2'25
Beat
by $0.07
Q1'25
Beat
by $0.20
Q4'24
Beat
by $0.16
The last earnings report on October 28 showed earnings per share of $2.25, missing the estimate of $2.27. With 634.36K shares outstanding, the current market capitalization sits at 250.98B.
A.I.Advisor
published Dividends

NVS paid dividends on March 20, 2023

Novartis AG NVS Stock Dividends
А dividend of $3.70 per share was paid with a record date of March 20, 2023, and an ex-dividend date of March 09, 2023. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of health care and nutritional products

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
Lichtstrasse 35
Phone
+41 613241111
Employees
76057
Web
https://www.novartis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IWB374.390.25
+0.07%
iShares Russell 1000 ETF
ABOT40.61N/A
N/A
Abacus FCF Innovation Leaders ETF
RDIV52.91-0.09
-0.16%
Invesco S&P Ultra Dividend Revenue ETF
GOOY14.52-0.12
-0.82%
YieldMax GOOGL Option Income Stgy ETF
CBLS27.60-0.23
-0.84%
Clough Hedged Equity ETF

NVS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NVS has been closely correlated with GSK. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if NVS jumps, then GSK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVS
1D Price
Change %
NVS100%
+1.37%
GSK - NVS
67%
Closely correlated
-0.70%
AZN - NVS
64%
Loosely correlated
-1.58%
PFE - NVS
60%
Loosely correlated
+1.41%
JNJ - NVS
57%
Loosely correlated
+0.29%
AMGN - NVS
54%
Loosely correlated
-0.64%
More

Groups containing NVS

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVS
1D Price
Change %
NVS100%
+1.37%
NVS
(2 stocks)
97%
Closely correlated
-0.07%